Teva Pharmaceutical Industries Limited Share Price & Technical Analysis

TEVA · $34.07 (-0.26%)

Healthcare / Drug Manufacturers - Specialty & Generic

AI Score 36 · Bearish

$34.07

-0.26%

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-pot

Price chart

Seasonality

May has 3 positive and 2 negative years (last 5 years shown)

-3% return in May, 3% avg return in past 3 year May month.

9% return in 2026, 50% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
269%-2%-11%15%-3%9%
25-20%-6%-6%1%8%-1%-8%20%11%2%31%17%49%
2415%7%7%-1%21%-5%6%10%-3%2%-9%31%81%
2314%-6%-11%-2%-18%4%12%18%3%-16%14%6%19%
224%-5%16%-7%6%-18%25%-2%-8%9%-3%3%19%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 36/100

Bearish · Uptrend · Uptrend

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; COPAXONE to treat patients with relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO to treat neurodegenerative and movement disorders – chorea associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax budesonide and formoterol powder inhaler; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell S.A.; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$41.16B

P/E ratio

26.38

52W high

$37.35

52W low

$14.99

Volume

23,32,132

Beta

0.86

Related stocks in Healthcare

Frequently asked questions

What is Teva Pharmaceutical Industries Limited share price today?
Teva Pharmaceutical Industries Limited (TEVA) last traded around $34.07 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does TEVA have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for TEVA. Download the app for real-time alerts.
How can I analyze Teva Pharmaceutical Industries Limited stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro